Regulus Therapeutics Inc. (Nasdaq: RGLS) announced that Joseph P. "Jay" Hagan has been appointed Chief Operating Officer effective January 4 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE